House Bill 1193
117th Congress(2021-2022)
Cardiovascular Advances in Research and Opportunities Legacy Act
Became Law
Amendments
Became Public Law 117-244 on Dec 20, 2022
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1193
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
checkPassed on December 8, 2021
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7518)
Summary
Cardiovascular Advances in Research and Opportunities Legacy Act
This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart.
The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly.
The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.
December 1, 2022
July 12, 2022
May 25, 2022
December 9, 2021
December 8, 2021
December 8, 2021
February 22, 2021
Amendments (1)
Dec 01, 2022
Agreed to in Senate
1
Sponsorship
Senate Amendment 6504
In the nature of a substitute.
Agreed To
12/20/2022
Became Public Law No: 117-244.
12/20/2022
Signed by President.
12/16/2022
Presented to President.
12/05/2022
Motion to reconsider laid on the table Agreed to without objection.
12/05/2022
On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H8755)
12/05/2022
Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote.
12/05/2022
DEBATE - The House proceeded with forty minutes of debate on the Senate amendment to H.R. 1193.
12/05/2022
Mr. Pallone moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H8755-8756)
12/05/2022
Message on Senate action sent to the House.
12/01/2022
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S6947)
12/01/2022
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S6947)
12/01/2022
The committee substitute withdrawn by Unanimous Consent.
12/01/2022
Measure laid before Senate by unanimous consent. (consideration: CR S6946-6947)
07/12/2022
Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
07/12/2022
Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.
06/14/2022
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
05/25/2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
12/09/2021
Received in the Senate.
12/08/2021
The title of the measure was amended. Agreed to without objection.
12/08/2021
Motion to reconsider laid on the table Agreed to without objection.
12/08/2021
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7518)
12/08/2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7518)
12/08/2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 1193.
12/08/2021
Considered under suspension of the rules. (consideration: CR H7518-7522)
12/08/2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
12/08/2021
Placed on the Union Calendar, Calendar No. 153.
12/08/2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-212.
11/17/2021
Ordered to be Reported (Amended) by Voice Vote.
11/17/2021
Committee Consideration and Mark-up Session Held.
11/04/2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
11/04/2021
Subcommittee Consideration and Mark-up Session Held.
02/23/2021
Referred to the Subcommittee on Health.
02/22/2021
Referred to the House Committee on Energy and Commerce.
02/22/2021
Introduced in House
Public Record
Record Updated
Mar 8, 2023 8:26:26 PM